세계의 제약용 천연 전분 시장 보고서(2025년)

Pharmaceutical native starch is a natural, unmodified starch sourced from plants such as corn, potato, wheat, or tapioca, and is used as an excipient in pharmaceutical formulations. It serves various purposes such as acting as a binder, disintegrant, or filler in tablets and capsules, playing a key role in regulating medication release, enhancing stability, and ensuring proper tablet formation, all without the need for chemical or physical alteration.

The primary types of pharmaceutical native starches include potato starch, corn starch, and others. Potato starch, a fine white powder extracted from potato tubers, is recognized for its smooth texture and superior binding capabilities, making it well-suited for pharmaceutical tablet formulations. It is available in various formulation types, including oral solids, liquids, topical products, injectables, and controlled-release formulations. Its versatility allows it to function as a texturizer, moisture-retaining agent, bulking agent, emulsifier, and film-former. It is commonly used as a binder, coating agent, disintegrant, filler, stabilizer, and thickener, serving a wide range of end-users such as pharmaceutical manufacturers, contract research organizations (CROs), contract manufacturing organizations (CMOs), research and development labs, academic institutions, and more.

The pharmaceuticals native starch market research report is one of a series of new reports from The Business Research Company that provides pharmaceuticals native starch market statistics, including pharmaceuticals native starch industry global market size, regional shares, competitors with a pharmaceuticals native starch market share, pharmaceuticals native starch market segments, market trends, and opportunities, and any further data you may need to thrive in the pharmaceuticals native starch industry. This pharmaceuticals native starch market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pharmaceuticals native starch market size has grown strongly in recent years. It will grow from $5.65 billion in 2024 to $6.17 billion in 2025 at a compound annual growth rate (CAGR) of 9.1%. The growth observed in the past can be linked to a higher demand for natural excipients, increased pharmaceutical production, a growing preference for biocompatible ingredients, the expansion of generic drug manufacturing, and greater regulatory backing for natural ingredients.

The pharmaceuticals native starch market size is expected to see strong growth in the next few years. It will grow to $8.69 billion in 2029 at a compound annual growth rate (CAGR) of 8.9%. The growth expected in the forecast period is driven by rising investments in pharmaceutical innovation, a stronger focus on sustainable sourcing, the growing use of novel drug formulations, an increasing demand for clean-label pharmaceutical products, and higher healthcare spending in emerging markets. Key trends in the forecast period include advancements in starch processing technology, innovations in drug delivery systems, developments in bio-based pharmaceutical ingredients, ongoing research in plant-based excipients, and progress in solubility and stability solutions.

The growing prevalence of chronic diseases is expected to drive the expansion of the pharmaceutical native starch market in the coming years. Chronic diseases are long-term medical conditions that typically develop gradually and last for over a year. The rise in chronic diseases is largely due to an aging population, as older individuals are more prone to long-term health issues such as diabetes, cardiovascular diseases, arthritis, and cancer, which become more prevalent with age. Pharmaceutical native starch plays a significant role in managing chronic diseases by enhancing the stability of drug formulations, improving bioavailability, enabling controlled drug release, promoting patient adherence, and ultimately supporting the effectiveness and long-term management of chronic conditions. For example, in June 2024, the Australian Institute of Health and Welfare reported an increase in the death rate from chronic diseases, rising from 459 per 100,000 people in 2021 to 490 per 100,000 in 2022. As a result, the growing prevalence of chronic diseases is fueling the growth of the pharmaceutical native starch market.

Companies in the pharmaceutical native starch market are focusing on developing innovative products, such as plant-based textures, to improve drug formulation and patient compliance. Plant-based textures refer to the physical properties of plant-derived ingredients, such as thickness and gel strength, which help enhance the performance of native starch in pharmaceuticals by improving tablet binding, disintegration, and mouthfeel for more effective natural drug formulations. For example, in February 2024, Ingredion Incorporated, a U.S.-based food company, launched Novation Indulge 2940 starch, a clean-label texturizer designed to improve texture and stability in dairy and alternative dairy products. This innovative pharmaceutical native starch offers functional benefits that enhance drug formulation performance, bioavailability, and controlled release, while supporting the development of clean-label, sustainable products. NOVATION Indulge 2940 starch improves texture, stability, and consumer acceptance in both dairy and alternative dairy products, using clean-label, natural ingredients.

In September 2022, Roquette Freres, a France-based food company, acquired Crest Cellulose for an undisclosed sum. This acquisition aims to strengthen Roquette's position in the pharmaceutical excipients market by expanding its range of plant-based, pharmacopoeia-compliant solutions and meeting the growing demand for high-quality drug delivery ingredients, particularly in India and the Asia Pacific region. Crest Cellulose, an India-based manufacturer, specializes in producing pregelatinized starch and sodium starch glycolate.

Major players in the pharmaceuticals native starch market are Cargill Incorporated, Archer Daniels Midland Company, Ingredion Incorporated, Tereos SCA, Roquette Freres SA., AGRANA, Tate & Lyle Public Limited Company, Colorcon Inc., Grain Processing Corporation, Siam Modified Starch Co. Ltd., BENEO GmbH, Gulshan Polyols Ltd., SPAC Starch Products (India) Private Limited, Universal Starch-Chem Allied Ltd., Sanstar Biopolymers Ltd., Emsland Group, Hungrana Kft., Bluecraft Agro Pvt. Ltd., Visco Starch, and Shandong Liujia Pharmaceutical Excipient Co.Ltd.

North America was the largest region in the pharmaceuticals native starch market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in pharmaceuticals native starch report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the pharmaceuticals native starch market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pharmaceuticals native starch market consists of sales of sorghum starch, barley starch, sweet potato starch, and arrowroot starch. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pharmaceuticals Native Starch Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pharmaceuticals native starch market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pharmaceuticals native starch ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pharmaceuticals native starch market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Potato Starch; Corn Starch; Other Types
• 2) By Formulation Type: Oral Solid Dosage Forms; Liquid Dosage Forms; Topical Formulations; Injectable Drugs; Controlled Release Formulations
• 3) By Functionality: Texturizing Agent; Moisture Retention Agent; Bulking Agent; Emulsifying Agent; Film-Forming Agent
• 4) By Application: Binders And Coating Agents; Disintegrants; Fillers And Extenders; Stabilizers; Thickening Agents
• 5) By End-User: Pharmaceutical Manufacturers; Contract Research Organizations (CROs); Contract Manufacturing Organizations (CMOs); Research And Development Labs; Academic Institutions; Other End-users
• Subsegments:
• 1) By Potato Starch: Modified Potato Starch; Native Potato Starch
• 2) By Corn Starch: Modified Corn Starch; Native Corn Starch
• 3) By Other Types: Rice Starch; Wheat Starch; Tapioca Starch
• Companies Mentioned: Cargill Incorporated; Archer Daniels Midland Company; Ingredion Incorporated; Tereos SCA; Roquette Freres SA.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Pharmaceuticals Native Starch Market Characteristics

3. Pharmaceuticals Native Starch Market Trends And Strategies

4. Pharmaceuticals Native Starch Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Pharmaceuticals Native Starch Growth Analysis And Strategic Analysis Framework

• 5.1. Global Pharmaceuticals Native Starch PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Pharmaceuticals Native Starch Market Growth Rate Analysis
• 5.4. Global Pharmaceuticals Native Starch Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Pharmaceuticals Native Starch Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Pharmaceuticals Native Starch Total Addressable Market (TAM)

6. Pharmaceuticals Native Starch Market Segmentation

• 6.1. Global Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Potato Starch
• Corn Starch
• Other Types
• 6.2. Global Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Solid Dosage Forms
• Liquid Dosage Forms
• Topical Formulations
• Injectable Drugs
• Controlled Release Formulations
• 6.3. Global Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Texturizing Agent
• Moisture Retention Agent
• Bulking Agent
• Emulsifying Agent
• Film-Forming Agent
• 6.4. Global Pharmaceuticals Native Starch Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Binders And Coating Agents
• Disintegrants
• Fillers And Extenders
• Stabilizers
• Thickening Agents
• 6.5. Global Pharmaceuticals Native Starch Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmaceutical Manufacturers
• Contract Research Organizations (Cros)
• Contract Manufacturing Organizations (Cmos)
• Research And Development Labs
• Academic Institutions
• Other End-Users
• 6.6. Global Pharmaceuticals Native Starch Market, Sub-Segmentation Of Potato Starch, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Modified Potato Starch
• Native Potato Starch
• 6.7. Global Pharmaceuticals Native Starch Market, Sub-Segmentation Of Corn Starch, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Modified Corn Starch
• Native Corn Starch
• 6.8. Global Pharmaceuticals Native Starch Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Rice Starch
• Wheat Starch
• Tapioca Starch

7. Pharmaceuticals Native Starch Market Regional And Country Analysis

• 7.1. Global Pharmaceuticals Native Starch Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Pharmaceuticals Native Starch Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Pharmaceuticals Native Starch Market

• 8.1. Asia-Pacific Pharmaceuticals Native Starch Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Pharmaceuticals Native Starch Market

• 9.1. China Pharmaceuticals Native Starch Market Overview
• 9.2. China Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Pharmaceuticals Native Starch Market

• 10.1. India Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Pharmaceuticals Native Starch Market

• 11.1. Japan Pharmaceuticals Native Starch Market Overview
• 11.2. Japan Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Pharmaceuticals Native Starch Market

• 12.1. Australia Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Pharmaceuticals Native Starch Market

• 13.1. Indonesia Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Pharmaceuticals Native Starch Market

• 14.1. South Korea Pharmaceuticals Native Starch Market Overview
• 14.2. South Korea Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Pharmaceuticals Native Starch Market

• 15.1. Western Europe Pharmaceuticals Native Starch Market Overview
• 15.2. Western Europe Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Pharmaceuticals Native Starch Market

• 16.1. UK Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Pharmaceuticals Native Starch Market

• 17.1. Germany Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Pharmaceuticals Native Starch Market

• 18.1. France Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Pharmaceuticals Native Starch Market

• 19.1. Italy Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Pharmaceuticals Native Starch Market

• 20.1. Spain Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Pharmaceuticals Native Starch Market

• 21.1. Eastern Europe Pharmaceuticals Native Starch Market Overview
• 21.2. Eastern Europe Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Pharmaceuticals Native Starch Market

• 22.1. Russia Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Pharmaceuticals Native Starch Market

• 23.1. North America Pharmaceuticals Native Starch Market Overview
• 23.2. North America Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Pharmaceuticals Native Starch Market

• 24.1. USA Pharmaceuticals Native Starch Market Overview
• 24.2. USA Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Pharmaceuticals Native Starch Market

• 25.1. Canada Pharmaceuticals Native Starch Market Overview
• 25.2. Canada Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Pharmaceuticals Native Starch Market

• 26.1. South America Pharmaceuticals Native Starch Market Overview
• 26.2. South America Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Pharmaceuticals Native Starch Market

• 27.1. Brazil Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Pharmaceuticals Native Starch Market

• 28.1. Middle East Pharmaceuticals Native Starch Market Overview
• 28.2. Middle East Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Pharmaceuticals Native Starch Market

• 29.1. Africa Pharmaceuticals Native Starch Market Overview
• 29.2. Africa Pharmaceuticals Native Starch Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Pharmaceuticals Native Starch Market, Segmentation By Formulation Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Pharmaceuticals Native Starch Market, Segmentation By Functionality, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Pharmaceuticals Native Starch Market Competitive Landscape And Company Profiles

• 30.1. Pharmaceuticals Native Starch Market Competitive Landscape
• 30.2. Pharmaceuticals Native Starch Market Company Profiles
  • 30.2.1. Cargill Incorporated Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Archer Daniels Midland Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Ingredion Incorporated Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Tereos SCA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Roquette Freres SA. Overview, Products and Services, Strategy and Financial Analysis

31. Pharmaceuticals Native Starch Market Other Major And Innovative Companies

• 31.1. AGRANA
• 31.2. Tate & Lyle Public Limited Company
• 31.3. Colorcon Inc.
• 31.4. Grain Processing Corporation
• 31.5. Siam Modified Starch Co. Ltd.
• 31.6. BENEO GmbH
• 31.7. Gulshan Polyols Ltd.
• 31.8. SPAC Starch Products (India) Private Limited
• 31.9. Universal Starch-Chem Allied Ltd.
• 31.10. Sanstar Biopolymers Ltd.
• 31.11. Emsland Group
• 31.12. Hungrana Kft.
• 31.13. Bluecraft Agro Pvt. Ltd.
• 31.14. Visco Starch
• 31.15. Shandong Liujia Pharmaceutical Excipient Co.Ltd.

32. Global Pharmaceuticals Native Starch Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pharmaceuticals Native Starch Market

34. Recent Developments In The Pharmaceuticals Native Starch Market

35. Pharmaceuticals Native Starch Market High Potential Countries, Segments and Strategies

• 35.1 Pharmaceuticals Native Starch Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Pharmaceuticals Native Starch Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Pharmaceuticals Native Starch Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer